UncategorizedPhysicist, 90, joins experimental trial to challenge age limits Empower Meds / November 21, 2025
UncategorizedPromis Neurosciences announces $0.8 million direct offering – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedLife Biosciences partners with REMEDIS to advance cell therapies – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedNew research collaboration targets cellular rejuvenation Empower Meds / November 21, 2025
UncategorizedBlue Longevity raises €2 million to scale preventive health clinics Empower Meds / November 21, 2025
UncategorizedJupiter Neurosciences details Jotrol bioavailability milestone – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedAmprion expands access to Saamplify test for neurodegenerative disease – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedHumacyte reports first Symvess sale to military hospital – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedRepurposed drugs show promise in Alzheimer’s combo therapy Empower Meds / November 21, 2025
